title: [Drug-induced lupus erythematosus tumidus during treatment with adalimumab].
abstract: Patients treated with TNF-alpha inhibitors frequently have serum autoantibodies, but only a few develop clinically apparent lupus erythematosus. The TNF-alpha inhibitor adalimumab is a fully humanized antibody and seems to induce autoantibodies less frequently than other drugs of this group. We report on a patient with rheumatoid arthritis, who developed anti-histone antibodies and lupus tumidus after eight months on adalimumab therapy.
authors.affiliation: Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Leipzig AöR, Philipp-Rosenthal-Strasse 23-25, 04103 Leipzig. sirius.sohl@medizin.uni-leipzig.de
authors.forename: S
authors.initials: S
authors.lastname: Sohl
authors.forename: R
authors.initials: R
authors.lastname: Renner
authors.forename: U
authors.initials: U
authors.lastname: Winter
authors.forename: M
authors.initials: M
authors.lastname: Bodendorf
authors.forename: U
authors.initials: U
authors.lastname: Paasch
authors.forename: J C
authors.initials: JC
authors.lastname: Simon
authors.forename: R
authors.initials: R
authors.lastname: Treudler
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control; D005260:Female; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000175:diagnosis* / Q000517:prevention & control
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab